Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)
United Arab Emirates flag United Arab Emirates · Delayed Price · Currency is AED
1.020
-0.020 (-1.92%)
At close: Sep 2, 2026

ADX:JULPHAR Cash Flow Statement

Millions AED. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
97172.244.6-99.1-29.464.4
Depreciation & Amortization
47.758135.4141.6132104.8
Loss (Gain) From Sale of Assets
149---0.10.1-
Asset Writedown & Restructuring Costs
-0.91.5---
Loss (Gain) From Sale of Investments
-1.9-1.9-0.8-1-7.9
Loss (Gain) on Equity Investments
-----31.4
Provision & Write-off of Bad Debts
5.34.79.412.772
Other Operating Activities
14.7-85.191.2139.442.8-109.7
Change in Accounts Receivable
-174.6-55.5-23.910.6-68.9349.8
Change in Inventory
-21.9-35.4-48.2-36.1-42.9-72.3
Change in Accounts Payable
86.843.1-38.9-57-18.2-322.4
Operating Cash Flow
68.3120.919093.619.346.2
Operating Cash Flow Growth
-53.09%-36.37%102.99%384.97%-58.23%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-41.5-35.7-43.7-22.1-63.7-44.4
Sale of Property, Plant & Equipment
-0.1-1.10.1--
Cash Acquisitions
------126.5
Divestitures
106.6713.5--51.4144.8
Sale (Purchase) of Intangibles
-8.4-10.3-9.4-4.9-1.7-
Investment in Securities
-117.322.4-29-3.33.1-16.1
Other Investing Activities
-1.3-102.663.62.4
Investing Cash Flow
-62679.9-78.4-24.2-7.3-39.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-859.3777.3---
Long-Term Debt Issued
---254.985665
Total Debt Issued
561.8859.3777.3254.985665
Short-Term Debt Repaid
--1,007-754.6---
Long-Term Debt Repaid
--518.8-141.1-93.6-76.7-573.9
Total Debt Repaid
-699-1,526-895.7-93.6-76.7-573.9
Net Debt Issued (Repaid)
-137.2-666.9-118.4161.38.391.1
Other Financing Activities
-7.7-19.9-71.9-83.3-34.6-21
Financing Cash Flow
-144.9-686.8-190.378-26.370.1

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.5-0.9-15.8-23-42.3-7.2
Net Cash Flow
-139.1113.1-94.5124.4-56.669.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
26.885.2146.371.5-44.41.8
Free Cash Flow Growth
-77.13%-41.76%104.61%---
Free Cash Flow Margin
2.43%7.92%14.74%5.60%-2.75%0.16%
Free Cash Flow Per Share
0.020.070.130.06-0.040.00
Levered Free Cash Flow
58.3557.59-288.032.8-64.74-226.98
Unlevered Free Cash Flow
66.8575.28-250.6537.99-39.68-212.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.835.971.957.934.622.1
Cash Income Tax Paid
4.121.23.96.44.6-
Change in Working Capital
-109.7-47.8-111-82.5-130-44.9